Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: Application to pharmacokinetic studies

Talanta

Volumn 76, Issue 5, 2008, Pages 1015-1021

  Bansal, Tripta ^a,b   Awasthi, Anshumali ^b   Jaggi, Manu ^b   Khar, Roop K ^a   Talegaonkar, Sushama ^a  

^a HAMDARD UNIVERSITY   (India)

^b DABUR RESEARCH FOUNDATION   (India)

Author keywords

Bile; Irinotecan (CPT 11); Pharmacokinetics; Plasma; SN 38; Ultraviolet detection

Indexed keywords

ACETONITRILE; BIOCHEMISTRY; BODY FLUIDS; CHROMATOGRAPHIC ANALYSIS; DICHLOROMETHANE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUIDS; METABOLITES; PHARMACOKINETICS; PLASMAS; RATS;

BILE; CHROMATOGRAPHIC SEPARATIONS; IRINOTECAN; LIQUID-LIQUID EXTRACTION; REVERSED-PHASE HIGH PERFORMANCE; REVERSED-PHASE LIQUID CHROMATOGRAPHIC METHODS; TERT-BUTYL METHYL ETHERS; ULTRA VIOLET DETECTION;

EXTRACTION;

EID: 50349101344     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2008.04.058     Document Type: Article

References (22)

1. Gupta E., Safa A.R., Wang X., and Ratain M.J. Cancer Res. 56 (1996) 1309
2. Stewart C.F., Zamboni W.C., Crom W.R., and Houghton P.J. Cancer Chemother. Pharmacol. 40 (1997) 259
3. Mathijssen R.H., van Alphen R.J., Verweij J., Loos W.J., Nooter K., Stoter G., and Sparreboom A. Clin. Cancer Res. 7 (2001) 2182
4. de Jong F.A., Mathijssen R.H., de Bruijn P., Loos W.J., Verweij J., and Sparreboom A. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 795 (2003) 383
5. Nakatomi K., Yoshikawa M., Oka M., Ikegami Y., Hayasaka S., Sano K., Shiozawa K., Kawabata S., Soda H., Ishikawa T., Tanabe S., and Kohno S. Biochem. Biophys. Res. Commun. 288 (2001) 827
6. Poujol S., Pinguet F., Malosse F., Astre C., Ychou M., Culine S., and Bressolle F. Clin. Chem. 49 (2003) 1900
7. Sparreboom A., de Bruijn P., de Jonge M.J., Loos W.J., Stoter G., Verweij J., and Nooter K. J. Chromatogr. B Biomed. Sci. Appl. 712 (1998) 225
8. Chollet D.F., Goumaz L., Renard A., Montay G., Vernillet L., Arnera V., and Mazzo D.J. J. Chromatogr. B Biomed. Sci. Appl. 718 (1998) 163
9. de Bruijn P., Verweij J., Loos W.J., Nooter K., Stoter G., and Sparreboom A. J. Chromatogr. B Biomed. Sci. Appl. 698 (1997) 277
10. Escoriaza J., Aldaz A., Castellanos C., Calvo E., and Giraldez J. J. Chromatogr. B Biomed. Sci. Appl. 740 (2000) 159
11. Guo W., Ahmad A., Khan S., Dahhani F., Wang Y.F., and Ahmad I. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 791 (2003) 85
12. Kaneda N., Hosokawa Y., and Yokokura T. Biol. Pharm. Bull. 20 (1997) 815
13. Schoemaker N.E., Rosing H., Jansen S., Schellens J.H., and Beijnen J.H. Ther. Drug Monit. 25 (2003) 120
14. Sumiyoshi H., Fujiwara Y., Ohune T., Yamaoka N., Tamura K., and Yamakido M. J. Chromatogr. B Biomed. Appl. 670 (1995) 309
15. Yang X., Hu Z., Chan S.Y., Goh B.C., Duan W., Chan E., and Zhou S. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 821 (2005) 221
16. Bansal T., Singh M., Mishra G., Talegaonkar S., Khar R.K., Jaggi M., and Mukherjee R. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 859 (2007) 261
17. Schoemaker N.E., Rosing H., Jansen S., Schoffski P., Rizzo J., Schellens J.H., and Beijnen J.H. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 775 (2002) 231
18. Topic Q2B: Validation of analytical procedures: Methodology. International Conference on Harmonisation (ICH) (1996)
19. Chu X.Y., Kato Y., Niinuma K., Sudo K.I., Hakusui H., and Sugiyama Y. J. Pharmacol. Exp. Ther. 281 (1997) 304
20. Srinubabu G., Patel R.S., Shedbalkar V.P., Rao A.A., Rao M.N., and Bhandaru V.V.R. J. Chromatogr. B 860 (2007) 202
21. http://www.fda.gov/cder/guidance/4252fnl.pdf
22. Lokiec F., Canal P., Gay C., Chatelut E., Armand J.P., Roche H., Bugat R., Goncalves E., and Mathieu-Boue A. Cancer Chemother. Pharmacol. 36 (1995) 79